Having demonstrated the association between ONECUT2 gene-body DNA methylation and expression with PCa progression and prognosis (Figs. 1 and 2), we aimed to leverage this novel discovery for clinical applications. This evidence concerns the gene ONECUT2 and posterior cortical atrophy.